REG - Byotrol PLC - Director Dealing

ByotrolAnnouncement

02/04/2024 15:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240402:nRSB0214Ja&default-theme=true

RNS Number : 0214J  Byotrol PLC  02 April 2024

 

 

Byotrol Plc

("Byotrol" or the "Company")

 

Director Dealing

 

Byotrol Plc (AIM: BYOT), the specialist infection prevention and control
company, announces that, on 2(nd) April 2024, David Traynor, Interim CEO of
the Company, purchased a total of 2,808,326 ordinary shares of 0.25p each
("Ordinary Shares") at an average price of 0.134p per Ordinary Share (the
"Purchase").

 

Following the Purchase, Mr. Traynor's beneficial holding is 12,743,623
Ordinary Shares, representing 2.8% of the total voting rights of the Company.
As announced on 28 July 2022, Mr. Traynor subscribed for convertible loan
notes in the Company, which if converted would represent an additional 0.34%
of the total voting rights of the Company.

 

 

For further information contact:

 

 Byotrol Plc
 Dr Trevor Francis, Non- Executive Chairman                                           +44 (0)1925 742 000
 David Traynor, Interim Chief Executive Officer

 Chris Sedwell, Chief Financial Officer

 Cavendish Capital Markets Limited (Nominated Adviser and Broker)                     +44 (0)20 7220 0500
 Geoff Nash/George Dollemore - Corporate Finance

 Nigel Birks/Harriet Ward - ECM

 Flagstaff Strategic and Investor Communications                                      +44 (0)20 7129 1474
 Tim Thompson/Andrea Seymour/Fergus Mellon                                            byotrol@flagstaffcomms.com (mailto:byotrol@flagstaffcomms.com)

 

 

 

The information communicated in this announcement contains inside information
for the purposes of Article 7 of the Market Abuse Regulation (EU) No.
596/2014.

 

Notes to editors

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and
control company, operating globally in the animal and human healthare,
industrial, institutional and consumer sectors, providing low toxicity
products with a broad-based and targeted efficacy across all microbial
classes; bacteria, viruses (including coronavirus), fungi, moulds,
mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing
products, where they can significantly improve their performance, especially
in personal hygiene, domestic and industrial disinfection, odour control, food
production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and
cleaner lives for everyone.

 

For more information, go to byotrol.com

 

 

The Notification of Dealing Form set out below is provided in accordance with
the requirements of the EU Market Abuse Regulation.

 

 1.                                Details of the person discharging managerial responsibilities / person closely
                                   associated
 a)                                Name                                                         David Traynor
 2.                                Reason for the Notification
 a)                                Position/status                                              Interim Chief Executive Officer
 b)                                Initial notification/Amendment                               Initial Notification
 3.                                Details of the issuer, emission allowance market participant, auction
                                   platform, auctioneer or auction monitor
 a)                                Name                                                         Byotrol plc
 b)                                LEI                                                          213800AJMTSTIPA59A34
 4.                                Details of the transaction(s): section to be repeated for (i) each type of
                                   instrument; (ii) each type of transaction; (iii) each date; and (iv) each
                                   place where transactions have been conducted
 a)                                Description of the Financial instrument, type of instrument  Ordinary shares of 0.25 pence per share
                                   Identification code                                          GB00B0999995
 b)                                Nature of the transaction                                    Purchase of Ordinary Shares
 c)                                Price(s) and volume(s)                                       Price(s)  Volume(s)
                                                                                                0.134p    2,808,326
 d)                                Aggregated information:

                                   ·Aggregated volume                                           See 4c) above

                                   · Price
 e)                                Date of the transaction                                      2 April 2024
 f)                                Place of the transaction                                     AIM, London Stock Exchange (XLON)

d)

Aggregated information:

·Aggregated volume

· Price

 

See 4c) above

e)

Date of the transaction

2 April 2024

f)

Place of the transaction

AIM, London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHZZGGDDZDGDZM